IP Library › Assignment 033793/0620
Patent Assignment
Reel/Frame 033793/0620

Change of Name

Recorded: 2014-09-22 Pages: 4
Assignor
LORUS THERAPEUTICS INC.
Executed: 2014-08-28
Assignee
APTOSE BIOSCIENCES INC.
2 MERIDIAN ROAD, TORONTO, ON, M9W 4Z7, CANADA
Covered Properties (14)
Antitimor Antisense Sequences Directed Against Ribonucleotide Reductase
Patent: 5,998,383 →
Application: 08/904,901 →
Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase
Patent: 6,593,305 →
Application: 09/249,247 →
Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase
Patent: 7,405,205 →
Application: 10/447,136 →
Publication: US 2004/0009948
2,4,5-Trisubstituted Imidazoles and Their Use as Anti-Microbial Agents
Patent: 7,884,120 →
Application: 10/525,690 →
Publication: US 2007/0105929
Aryl imidazoles and their use as anti-cancer agents
Patent: 8,969,372 →
Application: 10/579,149 →
Publication: US 2007/0123553
Use of Interleukin 17E for the Treatment of Cancer
Patent: 8,287,851 →
Application: 11/817,914 →
Publication: US 2011/0158936
2-Indolyl Imidazo [4,5-D] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
Patent: 8,148,392 →
Application: 11/915,257 →
Publication: US 2010/0168417
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
Patent: 7,968,526 →
Application: 12/691,664 →
Publication: US 2010/0197766
2,4,5-Trisubstituted Imidazoles and Their Use as Anti-Microbial Agents
Patent: 8,394,815 →
Application: 12/976,122 →
Publication: US 2011/0152337
2,4,5-Trisubstituted Imidazoles and Their Use as Anti-Microbial Agents
Patent: 8,987,305 →
Application: 13/778,458 →
Publication: US 2013/0177632
2-Substituted Imidazo[4,5-D]Phenanthroline Derivatives and Their Use in the Treatment of Cancer
Application: 61/803,627 →
Lor-253 and Other Therapeutic Agents for Treatment
Application: 61/887,285 →
Compositions, Biomarkers and Their Use in the Treatment of Cancer
Application: 61/919,023 →
Compositions, Biomarkers and Their Use in the Treatment of Cancer
Application: 62/017,505 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 22, 1998
From: WRIGHT, JIM A.; YOUNG, AIPING H.
To: GENESENSE TECHNOLOGIES
Reel/Frame 009274/0505 →
Assignment of Assignor's Interest Oct 4, 2001
From: WRIGHT, JIM A.; YOUNG, AIPING H.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 012244/0413 →
Assignment of Assignor's Interest Sep 23, 2002
From: WRIGHT, JIM A.; YOUNG, AIPING H.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 013315/0654 →
Assignment of Assignor's Interest Mar 12, 2007
From: LEE, YOON
To: LORUS THERAPEUTICS INC.
Reel/Frame 018999/0136 →
Assignment of Assignor's Interest Mar 12, 2007
From: HUESCA, MARIO; YOUNG, AIPING H.; AL-QAWASMEH, RAED
To: LORUS THERAPEUTICS INC.
Reel/Frame 018999/0172 →
Assignment of Assignor's Interest Jun 8, 2007
From: AL-QAWASMEH, RAED; YOUNG, AIPING H.; HUESCA, MARIO; LEE, YOON
To: LORUS THERAPEUTICS INC.
Reel/Frame 019401/0243 →
Assignment of Assignor's Interest Jul 12, 2007
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 019541/0983 →
Assignment of Assignor's Interest Aug 8, 2007
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 019670/0272 →
Assignment of Assignor's Interest Aug 14, 2007
From: 4325231 CANADA INC.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 019700/0017 →
Change of Name Sep 7, 2007
From: LORUS THERAPEUTICS INC.
To: 4325231 CANADA INC.
Reel/Frame 019807/0536 →
Change of Name Sep 12, 2007
From: LORUS THERAPEUTICS, INC.
To: 4325231 CANADA, INC.
Reel/Frame 019814/0114 →
Assignment of Assignor's Interest Sep 14, 2007
From: 4325231 CANADA INC.
To: GENESENSE TECHNOLOGIES, INC.
Reel/Frame 019828/0768 →
Assignment of Assignor's Interest Nov 18, 2008
From: HUESCA, MARIO; YOUNG, AIPING H.; LEE, YOON; KHINE, AYE AYE
To: LORUS THERAPEUTICS INC.
Reel/Frame 021851/0490 →
Assignment of Assignor's Interest Jun 8, 2009
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 022794/0635 →
Assignment of Assignor's Interest Jun 8, 2009
From: 4325231 CANADA INC.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 022794/0416 →
Change of Name Jun 8, 2009
From: LORUS THERAPEUTICS INC.
To: 4325231 CANADA INC.
Reel/Frame 022794/0140 →
Assignment of Assignor's Interest Jun 10, 2009
From: WRIGHT, JIM A.; YOUNG, AIPING H.; LEE, YOON; CAO, MING YU
To: LORUS THERAPEUTICS, INC.
Reel/Frame 022807/0149 →
Assignment of Assignor's Interest Jun 15, 2009
From: LORUS THERAPEUTICS INC.
To: 4325231 CANADA INC.
Reel/Frame 022823/0684 →
Assignment of Assignor's Interest Jun 18, 2009
From: 4325231 CANADA INC.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 022841/0844 →
Assignment of Assignor's Interest Jul 16, 2009
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 022966/0151 →
Assignment of Assignor's Interest Aug 18, 2009
From: LOCK, LISA
To: LORUS THERAPEUTICS, INC.
Reel/Frame 023112/0960 →
Assignment of Assignor's Interest Aug 18, 2009
From: GENESENSE TECHNOLOGIES, INC.
To: LORUS THERAPEUTICS, INC.
Reel/Frame 023112/0988 →
Assignment of Assignor's Interest Aug 26, 2009
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 023145/0289 →
Change of Name Jan 6, 2012
From: LORUS THERAPEUTICS INC.
To: 4325231 CANADA INC.
Reel/Frame 027493/0814 →
Assignment of Assignor's Interest Jan 6, 2012
From: AL-QAWASMEH, RAED; YOUNG, ALPING H.; HUESCA, MARIO; LEE, YOON
To: LORUS THERAPEUTICS INC.
Reel/Frame 027493/0396 →